Royal Fund Management, LLC

Position in GILD — Gilead Sciences, Inc.

CIK 1810099 Lady Lake, FL

Position in GILD

as of Jun 30, 2026 · filed Jul 20, 2026 Compact

Position Value

$325,072

+$63,614 QoQ

Shares Held

2,573

+37.2% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.04%

of 13F equity value

Holder Rank

#1,606

of 2,266 holders

Holding Since

Mar 2020

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Royal Fund Management, LLC holds $53,687,214 across 9 Drug Manufacturers - General names. GILD ranks #9 (0.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ABBV	AbbVie Inc.	50,828	$12,790,357
2	JNJ	Johnson & Johnson	37,731	$9,582,542
3	MRK	Merck & Co., Inc.	71,225	$9,152,412
4	AMGN	Amgen Inc	22,196	$8,037,615
5	LLY	ELI LILLY & Co	5,141	$6,166,270
6	BMY	Bristol Myers Squibb Co	67,139	$3,868,549
7	GSK	GSK plc	36,119	$1,893,357
8	PFE	Pfizer Inc	77,701	$1,871,040

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$325,072	2,573	+37.2%	Shares	Sole	2026-07-20
2026-03-31	$261,458	1,876	-79.6%	Shares	Sole	2026-05-19
2025-12-31	$1,126,875	9,181	+37.0%	Shares	Sole	2026-01-15
2025-09-30	$744,033	6,703	-4.6%	Shares	Sole	2025-10-29
2025-06-30	$779,083	7,027	+133.3%	Shares	Sole	2025-08-13
2025-03-31	$337,494	3,012	-86.4%	Shares	Sole	2025-05-14
2024-09-30	$1,856,217	22,140	+13.2%	Shares	Sole	2024-10-08
2024-06-30	$1,342,217	19,563	-12.8%	Shares	Sole	2024-07-18
2024-03-31	$1,643,730	22,440	+51.5%	Shares	Sole	2024-04-11
2023-12-31	$1,200,244	14,816	+433.1%	Shares	Sole	2024-02-06
2020-03-31	$207,758	2,779	—	Shares	Sole	2020-05-08
No filing history on record for this holder in this stock.